Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine
British Journal of Pharmacology · 09.03.2026
DOI: 10.1111/bph.70392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 09.03.2026. Verfasst von Xiaomeng Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 192 Literaturangaben. Gefördert von: National Science and Technology Major Projects of China.
Abstract (Originalsprache)
Systemic autoimmune diseases (SAIDs) arise from the convergence of genetic susceptibility, epigenetic dysregulation, metabolic imbalance and environmental triggers, ultimately leading to sustained disruption of immune homeostasis. Although targeted therapies and immunosuppressants have significantly improved disease control, their single pathway specificity limits their ability to restore long‐term immune tolerance. Preclinical evidence suggests that traditional Chinese medicine (TCM) may exert multi‐pathway regulatory effects across T‐ and B‐cell responses, innate immune activation and immunometabolic circuits. This review integrates current mechanistic evidence to illustrate how TCM‐based interventions complement the pathway specific actions of modern therapeutics through coordinated modulation of immune, metabolic, microbial and neuro‐immune networks. We further propose a ‘3C’ integrative framework—customisation, convergence and continuum—to describe how individualised patient profiling, multi‐target mechanistic convergence and stage‐specific treatment continuity can enhance the precision and durability of SAID management. Together, these insights provide a mechanistic rationale for developing evidence based and complementary integrative treatment strategies, whilst underscoring the need for improved standardisation, biomarker guided assessment and translational research to advance the clinical application of TCM informed therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Förderung
- National Science and Technology Major Projects of China
Zitieren
APA
Zhang, X., Zhang, L., Shi, C., Yan, L., Geng, Q., Yuan, S., He, X., & Lu, C. (2026). Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine. British Journal of Pharmacology. https://doi.org/10.1111/bph.70392
Vancouver
Zhang X, Zhang L, Shi C, Yan L, Geng Q, Yuan S, et al. Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine. British Journal of Pharmacology. 2026. doi:10.1111/bph.70392
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaomeng and Zhang, Lulu and Shi, Changqi and Yan, Lan and Geng, Qi and Yuan, Shuaipeng and He, Xiaojuan and Lu, Cheng},
title = {Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70392}
}
EUVIMED